Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Mi-Ri Gwon"'
Autor:
Jae-Hwa Lee, Mi-Ri Gwon, Jeung-Il Kim, Seung-young Hwang, Sook-Jin Seong, Young-Ran Yoon, Myungsoo Kim, Hyojeong Kim
Publikováno v:
Metabolites, Vol 14, Iss 5, p 250 (2024)
Soft tissue sarcoma (STS) is a relatively rare malignancy, accounting for about 1% of all adult cancers. It is known to have more than 70 subtypes. Its rarity, coupled with its various subtypes, makes early diagnosis challenging. The current standard
Externí odkaz:
https://doaj.org/article/f1feec4a3ad34f979b69dff5a4e61331
Autor:
Hae Won Lee, Woo Youl Kang, Wookjae Jung, Mi-Ri Gwon, Kyunghee Cho, Dong Heon Yang, Young-Ran Yoon, Sook Jin Seong
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 869 (2020)
Dyslipidemia is a major risk factor for development of atherosclerosis and cardiovascular disease (CVD). Effective lipid-lowering therapies has led to CVD risk reduction. This study evaluated the possible pharmacokinetic interactions between fenofibr
Externí odkaz:
https://doaj.org/article/87c7b0d179114769b7e3c57bf4a273e1
Autor:
Kyung Min Lee1,2, Mi-Ri Gwon1,3, Hae Won Lee1, Sook Jin Seong1 wintersj@knu.ac.kr, Young-Ran Yoon1,2,3 yry@knu.ac.kr
Publikováno v:
Translational & Clinical Pharmacology. Sep2021, Vol. 29 Issue 3, p160-170. 11p.
Autor:
Jae Hwa Lee, Mi-Ri Gwon, Ji Seo Park, Hae Won Lee, Duk-Hee Lee, Young-Ran Yoon, Sook Jin Seong
Publikováno v:
Journal of Chromatography B. 1221:123687
Autor:
Hae Won Lee, Woo Youl Kang, Mi-Ri Gwon, Eun Jung Choi, Eun Hee Kim, Kyunghee Cho, Bakhwan Lee, Sook Jin Seong, Young-Ran Yoon
Publikováno v:
Translational and clinical pharmacology. 30(3)
A new fixed-dose combination (FDC) formulation of raloxifene 60 mg and cholecalciferol 800 IU was developed to improve the medication compliance and overall efficacy of raloxifene treatment in postmenopausal osteoporosis patients. The aim of this stu
Autor:
Hae Won Lee, Woo Youl Kang, Ji Seo Park, Jae Hwa Lee, Mi-Ri Gwon, Dong Heon Yang, Eun Hee Kim, Soo-Jin Park, Young-Ran Yoon, Sook Jin Seong
Publikováno v:
Translational & Clinical Pharmacology; Jun2023, Vol. 31 Issue 2, p105-113, 9p
Autor:
Woo Youl Kang, Young-Ran Yoon, Sook Jin Seong, Dong Heon Yang, Mi-Ri Gwon, Hae Won Lee, Wang-Seob Shim, Kyung-Tae Lee, Seung Il Cho
Publikováno v:
Drug Design, Development and Therapy. 14:2101-2111
Objective Fimasartan, an angiotensin II type 1 receptor blocker, and linagliptin, a dipeptidyl-peptidase-4 inhibitor, are frequently coadministered to treat patients with hypertension and diabetes, respectively. This study sought to evaluate the phar
Autor:
Hae Won Lee, Woo Youl Kang, Wookjae Jung, Mi-Ri Gwon, Kyunghee Cho, Young-Ran Yoon, Sook Jin Seong
Publikováno v:
Drug Design, Development and Therapy.
Hae Won Lee,1,2 Woo Youl Kang,1,2 Wookjae Jung,1,2 Mi-Ri Gwon,1,2 Kyunghee Cho,3 Young-Ran Yoon,1,2 Sook Jin Seong1,2 1Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea; 2Department o
Autor:
Mi-Ri Gwon1,2, Young-Ran Yoon1,2, Young Mi Seol3, Young Jin Choi3, Dong-uk Kim4, Sangmin Choe5, Seung Hun Lee6, Seung-Young Hwang7, Hyojeong Kim3 leonkim80@pusan.ac.kr
Publikováno v:
Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji. Apr2019, Vol. 24 Issue 2, p61-67. 7p.